-
661
Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study
Published 2024-03-01“…The data of 47 patients with AIH who received immunosuppressive therapy from April 2001 to August 2023 were analyzed: 10 men (21 %), 37 women (79 %); the average age was 37 (17–66) years. …”
Get full text
Article -
662
Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia
Published 2024-11-01“…While there is no standardized treatment regimen, current therapeutic strategies are generally focused on combination immunosuppressive therapies. Despite early diagnosis and immunosuppressive therapy, the disease remains highly aggressive and is associated with a poor prognosis. …”
Get full text
Article -
663
YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer
Published 2023-01-01“…Conclusions. YAP1 mediates immunosuppressive microenvironment and poor prognosis in EGFR-mutant NSCLC population. …”
Get full text
Article -
664
Cryoablation combined with dual immune checkpoint blockade enhances antitumor efficacy in hepatocellular carcinoma model mice
Published 2024-12-01“…The percentages of immune cells and immunosuppressive cells were analyzed by flow cytometry. …”
Get full text
Article -
665
Transverse Myelitis Associated with Cryptococcus neoformans in an Immunocompetent Patient
Published 2022-01-01“…Cryptococcal infections are known to cause significant morbidity and mortality in immunosuppressed patients as it is difficult to eradicate even with adequate antifungal treatment. …”
Get full text
Article -
666
Tacrolimus toxicity management in a pregnant kidney transplant recipient with newly diagnosed human immunodeficiency virus: A case report
Published 2025-02-01“…Managing kidney transplant recipients during pregnancy presents significant challenges, particularly in balancing the interactions and safety concerns of immunosuppressive medications such as mycophenolate mofetil and tacrolimus. …”
Get full text
Article -
667
SLE and Non-Hodgkin’s Lymphoma: A Case Series and Review of the Literature
Published 2017-01-01“…We will also review and discuss the implications of immunosuppressives in SLE-related lymphoma and the role of mycophenolate mofetil in SLE-related primary CNS lymphoma development.…”
Get full text
Article -
668
Pregnancy after kidney and liver transplantation
Published 2024-04-01“…This article examines the management of pregnancy in kidney and liver transplant recipients, focusing on pre-pregnancy counselling, trimester-specific care, the teratogenic effects of immunosuppressive drugs, and the role of the multidisciplinary team. …”
Get full text
Article -
669
Artificial intelligence in kidney transplantation: a 30-year bibliometric analysis of research trends, innovations, and future directions
Published 2025-12-01“…Key research themes include AI-driven advancements in donor matching, deep learning for post-transplant monitoring, and machine learning algorithms for personalized immunosuppressive therapies. The findings underscore a rapid expansion in AI applications since 2017, with emerging trends in personalized medicine, multimodal data fusion, and telehealth. …”
Get full text
Article -
670
Culture and Use of Mesenchymal Stromal Cells in Phase I and II Clinical Trials
Published 2010-01-01“…Moreover, MSCs have immunosuppressive properties related to non-HLA restricted immunosuppressive capacities. …”
Get full text
Article -
671
Hepatitis C Virus, Cryoglobulinemia, and Kidney: Novel Evidence
Published 2012-01-01“…Various approaches have been tried for the treatment of HCV-related glomerulonephritis, including immunosuppressive therapy (corticosteroids and cytotoxic agents), plasma exchange and antiviral agents. …”
Get full text
Article -
672
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Published 2023-04-01“…Contributing to the poor prognosis of PDAC is the lack of early detection, a complex network of signaling pathways and molecular mechanisms, a dense and desmoplastic stroma, and an immunosuppressive tumor microenvironment. A recent shift toward a neoadjuvant approach to treating PDAC has been sparked by the numerous benefits neoadjuvant therapy (NAT) has to offer compared with upfront surgery. …”
Get full text
Article -
673
Enhancement of Cytomegalovirus-Specific Cytokine Production after Modulation of the Costimulation in Kidney Transplant Patients
Published 2019-01-01“…Kidney transplantation is the therapy of choice for patients with end stage renal disease. Due to immunosuppressive treatment, patients are at risk for opportunistic infections. …”
Get full text
Article -
674
IGF2BP2 Shapes the Tumor Microenvironment by Regulating Monocyte and Macrophage Recruitment in Bladder Cancer
Published 2024-12-01“…Furthermore, IGF2BP2 expression was linked to immunosuppressive M2‐like and SPP1+ macrophages, contributing to an angiogenesis‐promoting and immunosuppressive TME. …”
Get full text
Article -
675
Modeling BK Virus Infection in Renal Transplant Recipients
Published 2024-12-01“…Kidney transplant recipients require a lifelong protocol of immunosuppressive therapy to prevent graft rejection. However, these same medications leave them susceptible to opportunistic infections. …”
Get full text
Article -
676
Challenges in Treating Statin-Associated Necrotizing Myopathy
Published 2021-01-01“…Multiple patients required several immunosuppressant medications as well as intravenous immunoglobulin (IVIG) to achieve disease control. …”
Get full text
Article -
677
The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence
Published 2014-01-01“…Clearly there is a need for better immunosuppressive agents that maintain similar rates of efficacy and renal function whilst minimizing adverse effects. …”
Get full text
Article -
678
Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated with Etanercept – A Tumour Necrosis Factor-Alpha Antagonist
Published 2001-01-01“…Little clinical improvement occurred with immunosuppressive therapy. Only after the addition of etanercept, a TNF- α p75 receptor antagonist, did complete clinical resolution occur. …”
Get full text
Article -
679
A Behcet’s Disease Patient with Right Ventricular Thrombus, Pulmonary Artery Aneurysms, and Deep Vein Thrombosis Complicating Recurrent Pulmonary Thromboembolism
Published 2013-01-01“…At the controls after three months of immunosuppressive and anticoagulant therapies, some clinical and radiological improvements were recognized. …”
Get full text
Article -
680
Xylohypha bantiana Multiple Brain Abscesses in a Patient with Systemic Lupus Erythematosus
Published 2003-01-01“…We report on a 72-year-old man who, while taking several immunosuppressive medications for systemic lupus erythematosus, presented with multiple bilateral cerebral abscesses caused by X bantiana. …”
Get full text
Article